Clinical Effectiveness of 5 Different Mouthwashes in the Treatment of Generalised Gingivitis

January 28, 2021 updated by: Blagovesta Yaneva, Plovdiv Medical University

Randomised Controlled Trial Comparing the Clinical Effectiveness of 5 Mouthwashes Based on Essential Oils, Chlorhexidine, Hydrogen Peroxide and Prebiotic, in Gingivitis Treatment

The aim of the present study is to evaluate the efficacy of 5 mouthwashes, based on different ingredients, in the treatment of generalised gingivitis.

Study Overview

Detailed Description

The present clinical study aims to investigate the clinical efficacy of 5 mouthwashes based on different active substances. The study include 180 patients divided into 6 groups of 30 patients, each group rinse with one of the following mouthwashes - mouthwash based on essential oils (menthol, thymol and eucalyptus), mouthwash based on essential oils (menthol, thymol and eucalyptus) and 0.12% chlorhexidine, mouthwash based on 0,8 % hydrogen peroxide, mouthwash based on prebiotic, water based on 0.2% chlorhexidine, placebo mouthwash. Inclusion criteria are: generalized gingival inflammation, plaque index of Turesky, 1970 > 1.95, gingival index of Loe & Silness, 1963 > 0.95, no systemic diseases, no systemic medication, lack of severely damaged teeth, no large fillings, no orthodontic treatment. Patients are motivated and instructed to maintain proper and optimal personal oral hygiene. All participants undergo professional mechanical plaque removal. After instrumentation participants are instructed to rinse with 15 ml mouthwash 2 times a day for 21 days. Researchers control the amount of mouthwash used by giving a new bottle of mouthwash with the required amount for 1 patient for 1 week at the beginning of each week and taking back the bottle from the previous week. During the study period, patients are monitored on days 14 and 21, examining plaque index of Turesky, 1970, gingival index of Loe & Silness, 1963, bleeding index of Ainamo & Bay, 1975, side effects like staining, burning itching, oral lesions. At the end of the study (day 21), patients complete a questionnaire.

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Plovdiv, Bulgaria, 4000
        • Blagovesta Yaneva

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Plaque Index (Turesky, 1970) > 1,95;
  • Gingival Index (Loe & Silness, 1963) > 0,95;
  • Bleeding Index (Animo & Bay, 1975) > 30 %;
  • no systemic diseases;
  • no systemic medication.

Exclusion Criteria:

  • severely destroyed teeth;
  • crowns;
  • non correct obturation class II and V;
  • orthodontic treatment;
  • third molars.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Essential oils
Mouthwash based on essential oils - menthol, eucalypts oil, thymol, alcohol
Participants were asked to rinse with 15 ml mouthwash twice daily for 21 days.
Experimental: Essential oils in combination with clorhexidine 0,12%
Mouthwash based on essential oils - mentol, eucalypt oil, thymol, alcohol, and 0,12% chlorhexidine
Participants were asked to rinse with 15 ml mouthwash twice daily for 21 days.
Placebo Comparator: Placebo mouthwash
Water, colorant, sweetener
Participants were asked to rinse with 15 ml mouthwash twice daily for 21 days.
Experimental: Clorhexidine 0,20% in combination with aroma oils
Mouthwash based on 0,20% chorhexidine without alcohol in combination with aroma oils of rose and lavender
Participants were asked to rinse with 15 ml mouthwash twice daily for 21 days.
Experimental: Prebiotic
Mouthwash based on prebiotic
Participants were asked to rinse with 15 ml mouthwash twice daily for 21 days.
Experimental: Hydrogen peroxide
Mouthwash based on 0,8% hydrogen peroxide in combination with menthol and eucalypts oil
Participants were asked to rinse with 15 ml mouthwash twice daily for 21 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline bleeding index at 21 day.
Time Frame: 21 days
Recording the bleeding index of Ainamo&Bay, 1975. The index reports the presence or absence of bleeding on probing in 4 sites around every tooth. It is calculated in % for the whole dentition.
21 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline gingival index at 21 day.
Time Frame: 21 days
The gingival index of Loe, 1967 estimates the inflammation of the gingiva in 4 sites around every tooth, examining the colour, the texture, the consistency and the bleeding of the gingiva.
21 days
Change from baseline oral hygiene index at 21 day.
Time Frame: 21 days
The index of Turesky, 1970 is used. After discolouration of the plaque its distribution is measured in 6 sites of every tooth. The mean value is calculated by summing the individual values for each tooth and dividing the sum by all the places examined.
21 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Blagovesta Yaneva, PhD, Plovdiv Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Actual)

December 20, 2020

Study Completion (Actual)

December 20, 2020

Study Registration Dates

First Submitted

January 22, 2021

First Submitted That Met QC Criteria

January 28, 2021

First Posted (Actual)

February 1, 2021

Study Record Updates

Last Update Posted (Actual)

February 1, 2021

Last Update Submitted That Met QC Criteria

January 28, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gingivitis

Clinical Trials on Essential oils

Subscribe